/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / RyCarma

RyCarma

United States

RyCarma Therapeutics is a clinical-stage company developing a novel class of therapeutics for serious diseases with high unmet need in which ryanodine receptors play a critical role in disease progression.

Healthcare & Biotech

RyCarma, based in United States, has 2 investors on file, among them Kurma Partners and Pontifax. Its site was last checked 13 Nov 2026: site answers.

rycarma.com

Investors

2 investors on file
InvestorEvidenceType
Kurma PartnersPortfolio pageVenture capital
PontifaxPortfolio pageVenture capital

More from Kurma Partners

56 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (94%), AI & Machine Learning (4%), Fintech (2%).

Adcytherix SASAdcytherix is building an antibody-drug conjugate powerhouse to advanc…Alveus TherapeuticsAlveus Therapeutics develops treatments for obesity and weight loss ma…AsceneuronAsceneuron discovers and develops therapeutics for neurodegenerative d…CardiologsCardiologs provides ECG analysis software solutions utilizing clinical…Charles CoThe company provides online medical consultations and personalized dia…

See Kurma Partners' full profile · Who invests alongside it

More from Pontifax

33 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (97%), AI & Machine Learning (3%).

AbcuroAbcuro develops therapies for autoimmune diseases and cancer.AdcendoAdcendo is developing a new generation of antibody-drug conjugates to …Adcytherix SASAdcytherix is building an antibody-drug conjugate powerhouse to advanc…Climb BioClimb Bio develops differentiated monoclonal antibodies for immune-med…Crystalys TherapeuticsCrystalys Therapeutics develops new therapeutics to address unmet medi…

See Pontifax's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get RyCarma and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Kurma Partners adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/rycarma.com/investors

# also
GET /v1/companies/rycarma.com
GET /v1/companies/rycarma.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing